Global H1 Receptor Antagonist Supply, Demand and Key Producers, 2023-2029
The global H1 Receptor Antagonist market size is expected to reach $ 58730 million by 2029, rising at a market growth of 7.4% CAGR during the forecast period (2023-2029).
H1 receptor antagonists (H1 receptor antagonists, referred to as H1RAS) prevent histamine from acting on target cells by reversibly competing for histamine receptor sites on cells, and play a role by blocking and antagonizing H1 receptors. Anti-allergic effect, in order to prevent a series of physiological reactions from happening.
This report studies the global H1 Receptor Antagonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for H1 Receptor Antagonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of H1 Receptor Antagonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global H1 Receptor Antagonist total production and demand, 2018-2029, (K Units)
Global H1 Receptor Antagonist total production value, 2018-2029, (USD Million)
Global H1 Receptor Antagonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global H1 Receptor Antagonist consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: H1 Receptor Antagonist domestic production, consumption, key domestic manufacturers and share
Global H1 Receptor Antagonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global H1 Receptor Antagonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global H1 Receptor Antagonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global H1 Receptor Antagonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Bayer, Pfizer, LETI, Novartis, Hypera Pharma, Woodward, Merck and Johnson and Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World H1 Receptor Antagonist market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global H1 Receptor Antagonist Market, By Region:
1. How big is the global H1 Receptor Antagonist market?
2. What is the demand of the global H1 Receptor Antagonist market?
3. What is the year over year growth of the global H1 Receptor Antagonist market?
4. What is the production and production value of the global H1 Receptor Antagonist market?
5. Who are the key producers in the global H1 Receptor Antagonist market?
6. What are the growth factors driving the market demand?
H1 receptor antagonists (H1 receptor antagonists, referred to as H1RAS) prevent histamine from acting on target cells by reversibly competing for histamine receptor sites on cells, and play a role by blocking and antagonizing H1 receptors. Anti-allergic effect, in order to prevent a series of physiological reactions from happening.
This report studies the global H1 Receptor Antagonist production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for H1 Receptor Antagonist, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of H1 Receptor Antagonist that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global H1 Receptor Antagonist total production and demand, 2018-2029, (K Units)
Global H1 Receptor Antagonist total production value, 2018-2029, (USD Million)
Global H1 Receptor Antagonist production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global H1 Receptor Antagonist consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: H1 Receptor Antagonist domestic production, consumption, key domestic manufacturers and share
Global H1 Receptor Antagonist production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global H1 Receptor Antagonist production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global H1 Receptor Antagonist production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global H1 Receptor Antagonist market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva, Bayer, Pfizer, LETI, Novartis, Hypera Pharma, Woodward, Merck and Johnson and Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World H1 Receptor Antagonist market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global H1 Receptor Antagonist Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- First Generation H1RAS
- Second-generation H1RAS
- Third-generation H1RAS
- Hospital
- Retail Pharmacy
- Other
- Teva
- Bayer
- Pfizer
- LETI
- Novartis
- Hypera Pharma
- Woodward
- Merck
- Johnson and Johnson
- Ethical pharma
- Gems pharma
- KPL Pharma
- GlaxoSmithKline
- Ying Yuan
- Schering-Plough
1. How big is the global H1 Receptor Antagonist market?
2. What is the demand of the global H1 Receptor Antagonist market?
3. What is the year over year growth of the global H1 Receptor Antagonist market?
4. What is the production and production value of the global H1 Receptor Antagonist market?
5. Who are the key producers in the global H1 Receptor Antagonist market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 H1 Receptor Antagonist Introduction
1.2 World H1 Receptor Antagonist Supply & Forecast
1.2.1 World H1 Receptor Antagonist Production Value (2018 & 2022 & 2029)
1.2.2 World H1 Receptor Antagonist Production (2018-2029)
1.2.3 World H1 Receptor Antagonist Pricing Trends (2018-2029)
1.3 World H1 Receptor Antagonist Production by Region (Based on Production Site)
1.3.1 World H1 Receptor Antagonist Production Value by Region (2018-2029)
1.3.2 World H1 Receptor Antagonist Production by Region (2018-2029)
1.3.3 World H1 Receptor Antagonist Average Price by Region (2018-2029)
1.3.4 North America H1 Receptor Antagonist Production (2018-2029)
1.3.5 Europe H1 Receptor Antagonist Production (2018-2029)
1.3.6 China H1 Receptor Antagonist Production (2018-2029)
1.3.7 Japan H1 Receptor Antagonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 H1 Receptor Antagonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 H1 Receptor Antagonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World H1 Receptor Antagonist Demand (2018-2029)
2.2 World H1 Receptor Antagonist Consumption by Region
2.2.1 World H1 Receptor Antagonist Consumption by Region (2018-2023)
2.2.2 World H1 Receptor Antagonist Consumption Forecast by Region (2024-2029)
2.3 United States H1 Receptor Antagonist Consumption (2018-2029)
2.4 China H1 Receptor Antagonist Consumption (2018-2029)
2.5 Europe H1 Receptor Antagonist Consumption (2018-2029)
2.6 Japan H1 Receptor Antagonist Consumption (2018-2029)
2.7 South Korea H1 Receptor Antagonist Consumption (2018-2029)
2.8 ASEAN H1 Receptor Antagonist Consumption (2018-2029)
2.9 India H1 Receptor Antagonist Consumption (2018-2029)
3 WORLD H1 RECEPTOR ANTAGONIST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World H1 Receptor Antagonist Production Value by Manufacturer (2018-2023)
3.2 World H1 Receptor Antagonist Production by Manufacturer (2018-2023)
3.3 World H1 Receptor Antagonist Average Price by Manufacturer (2018-2023)
3.4 H1 Receptor Antagonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global H1 Receptor Antagonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for H1 Receptor Antagonist in 2022
3.5.3 Global Concentration Ratios (CR8) for H1 Receptor Antagonist in 2022
3.6 H1 Receptor Antagonist Market: Overall Company Footprint Analysis
3.6.1 H1 Receptor Antagonist Market: Region Footprint
3.6.2 H1 Receptor Antagonist Market: Company Product Type Footprint
3.6.3 H1 Receptor Antagonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: H1 Receptor Antagonist Production Value Comparison
4.1.1 United States VS China: H1 Receptor Antagonist Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: H1 Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: H1 Receptor Antagonist Production Comparison
4.2.1 United States VS China: H1 Receptor Antagonist Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: H1 Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: H1 Receptor Antagonist Consumption Comparison
4.3.1 United States VS China: H1 Receptor Antagonist Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: H1 Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based H1 Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.4.1 United States Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers H1 Receptor Antagonist Production Value (2018-2023)
4.4.3 United States Based Manufacturers H1 Receptor Antagonist Production (2018-2023)
4.5 China Based H1 Receptor Antagonist Manufacturers and Market Share
4.5.1 China Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers H1 Receptor Antagonist Production Value (2018-2023)
4.5.3 China Based Manufacturers H1 Receptor Antagonist Production (2018-2023)
4.6 Rest of World Based H1 Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers H1 Receptor Antagonist Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers H1 Receptor Antagonist Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World H1 Receptor Antagonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 First Generation H1RAS
5.2.2 Second-generation H1RAS
5.2.3 Third-generation H1RAS
5.3 Market Segment by Type
5.3.1 World H1 Receptor Antagonist Production by Type (2018-2029)
5.3.2 World H1 Receptor Antagonist Production Value by Type (2018-2029)
5.3.3 World H1 Receptor Antagonist Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World H1 Receptor Antagonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World H1 Receptor Antagonist Production by Application (2018-2029)
6.3.2 World H1 Receptor Antagonist Production Value by Application (2018-2029)
6.3.3 World H1 Receptor Antagonist Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Details
7.1.2 Teva Major Business
7.1.3 Teva H1 Receptor Antagonist Product and Services
7.1.4 Teva H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Recent Developments/Updates
7.1.6 Teva Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer H1 Receptor Antagonist Product and Services
7.2.4 Bayer H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer H1 Receptor Antagonist Product and Services
7.3.4 Pfizer H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 LETI
7.4.1 LETI Details
7.4.2 LETI Major Business
7.4.3 LETI H1 Receptor Antagonist Product and Services
7.4.4 LETI H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 LETI Recent Developments/Updates
7.4.6 LETI Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis H1 Receptor Antagonist Product and Services
7.5.4 Novartis H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Hypera Pharma
7.6.1 Hypera Pharma Details
7.6.2 Hypera Pharma Major Business
7.6.3 Hypera Pharma H1 Receptor Antagonist Product and Services
7.6.4 Hypera Pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hypera Pharma Recent Developments/Updates
7.6.6 Hypera Pharma Competitive Strengths & Weaknesses
7.7 Woodward
7.7.1 Woodward Details
7.7.2 Woodward Major Business
7.7.3 Woodward H1 Receptor Antagonist Product and Services
7.7.4 Woodward H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Woodward Recent Developments/Updates
7.7.6 Woodward Competitive Strengths & Weaknesses
7.8 Merck
7.8.1 Merck Details
7.8.2 Merck Major Business
7.8.3 Merck H1 Receptor Antagonist Product and Services
7.8.4 Merck H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Merck Recent Developments/Updates
7.8.6 Merck Competitive Strengths & Weaknesses
7.9 Johnson and Johnson
7.9.1 Johnson and Johnson Details
7.9.2 Johnson and Johnson Major Business
7.9.3 Johnson and Johnson H1 Receptor Antagonist Product and Services
7.9.4 Johnson and Johnson H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Johnson and Johnson Recent Developments/Updates
7.9.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.10 Ethical pharma
7.10.1 Ethical pharma Details
7.10.2 Ethical pharma Major Business
7.10.3 Ethical pharma H1 Receptor Antagonist Product and Services
7.10.4 Ethical pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Ethical pharma Recent Developments/Updates
7.10.6 Ethical pharma Competitive Strengths & Weaknesses
7.11 Gems pharma
7.11.1 Gems pharma Details
7.11.2 Gems pharma Major Business
7.11.3 Gems pharma H1 Receptor Antagonist Product and Services
7.11.4 Gems pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Gems pharma Recent Developments/Updates
7.11.6 Gems pharma Competitive Strengths & Weaknesses
7.12 KPL Pharma
7.12.1 KPL Pharma Details
7.12.2 KPL Pharma Major Business
7.12.3 KPL Pharma H1 Receptor Antagonist Product and Services
7.12.4 KPL Pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 KPL Pharma Recent Developments/Updates
7.12.6 KPL Pharma Competitive Strengths & Weaknesses
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Details
7.13.2 GlaxoSmithKline Major Business
7.13.3 GlaxoSmithKline H1 Receptor Antagonist Product and Services
7.13.4 GlaxoSmithKline H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 GlaxoSmithKline Recent Developments/Updates
7.13.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.14 Ying Yuan
7.14.1 Ying Yuan Details
7.14.2 Ying Yuan Major Business
7.14.3 Ying Yuan H1 Receptor Antagonist Product and Services
7.14.4 Ying Yuan H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ying Yuan Recent Developments/Updates
7.14.6 Ying Yuan Competitive Strengths & Weaknesses
7.15 Schering-Plough
7.15.1 Schering-Plough Details
7.15.2 Schering-Plough Major Business
7.15.3 Schering-Plough H1 Receptor Antagonist Product and Services
7.15.4 Schering-Plough H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Schering-Plough Recent Developments/Updates
7.15.6 Schering-Plough Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 H1 Receptor Antagonist Industry Chain
8.2 H1 Receptor Antagonist Upstream Analysis
8.2.1 H1 Receptor Antagonist Core Raw Materials
8.2.2 Main Manufacturers of H1 Receptor Antagonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 H1 Receptor Antagonist Production Mode
8.6 H1 Receptor Antagonist Procurement Model
8.7 H1 Receptor Antagonist Industry Sales Model and Sales Channels
8.7.1 H1 Receptor Antagonist Sales Model
8.7.2 H1 Receptor Antagonist Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 H1 Receptor Antagonist Introduction
1.2 World H1 Receptor Antagonist Supply & Forecast
1.2.1 World H1 Receptor Antagonist Production Value (2018 & 2022 & 2029)
1.2.2 World H1 Receptor Antagonist Production (2018-2029)
1.2.3 World H1 Receptor Antagonist Pricing Trends (2018-2029)
1.3 World H1 Receptor Antagonist Production by Region (Based on Production Site)
1.3.1 World H1 Receptor Antagonist Production Value by Region (2018-2029)
1.3.2 World H1 Receptor Antagonist Production by Region (2018-2029)
1.3.3 World H1 Receptor Antagonist Average Price by Region (2018-2029)
1.3.4 North America H1 Receptor Antagonist Production (2018-2029)
1.3.5 Europe H1 Receptor Antagonist Production (2018-2029)
1.3.6 China H1 Receptor Antagonist Production (2018-2029)
1.3.7 Japan H1 Receptor Antagonist Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 H1 Receptor Antagonist Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 H1 Receptor Antagonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World H1 Receptor Antagonist Demand (2018-2029)
2.2 World H1 Receptor Antagonist Consumption by Region
2.2.1 World H1 Receptor Antagonist Consumption by Region (2018-2023)
2.2.2 World H1 Receptor Antagonist Consumption Forecast by Region (2024-2029)
2.3 United States H1 Receptor Antagonist Consumption (2018-2029)
2.4 China H1 Receptor Antagonist Consumption (2018-2029)
2.5 Europe H1 Receptor Antagonist Consumption (2018-2029)
2.6 Japan H1 Receptor Antagonist Consumption (2018-2029)
2.7 South Korea H1 Receptor Antagonist Consumption (2018-2029)
2.8 ASEAN H1 Receptor Antagonist Consumption (2018-2029)
2.9 India H1 Receptor Antagonist Consumption (2018-2029)
3 WORLD H1 RECEPTOR ANTAGONIST MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World H1 Receptor Antagonist Production Value by Manufacturer (2018-2023)
3.2 World H1 Receptor Antagonist Production by Manufacturer (2018-2023)
3.3 World H1 Receptor Antagonist Average Price by Manufacturer (2018-2023)
3.4 H1 Receptor Antagonist Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global H1 Receptor Antagonist Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for H1 Receptor Antagonist in 2022
3.5.3 Global Concentration Ratios (CR8) for H1 Receptor Antagonist in 2022
3.6 H1 Receptor Antagonist Market: Overall Company Footprint Analysis
3.6.1 H1 Receptor Antagonist Market: Region Footprint
3.6.2 H1 Receptor Antagonist Market: Company Product Type Footprint
3.6.3 H1 Receptor Antagonist Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: H1 Receptor Antagonist Production Value Comparison
4.1.1 United States VS China: H1 Receptor Antagonist Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: H1 Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: H1 Receptor Antagonist Production Comparison
4.2.1 United States VS China: H1 Receptor Antagonist Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: H1 Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: H1 Receptor Antagonist Consumption Comparison
4.3.1 United States VS China: H1 Receptor Antagonist Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: H1 Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based H1 Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.4.1 United States Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers H1 Receptor Antagonist Production Value (2018-2023)
4.4.3 United States Based Manufacturers H1 Receptor Antagonist Production (2018-2023)
4.5 China Based H1 Receptor Antagonist Manufacturers and Market Share
4.5.1 China Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers H1 Receptor Antagonist Production Value (2018-2023)
4.5.3 China Based Manufacturers H1 Receptor Antagonist Production (2018-2023)
4.6 Rest of World Based H1 Receptor Antagonist Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers H1 Receptor Antagonist Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers H1 Receptor Antagonist Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World H1 Receptor Antagonist Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 First Generation H1RAS
5.2.2 Second-generation H1RAS
5.2.3 Third-generation H1RAS
5.3 Market Segment by Type
5.3.1 World H1 Receptor Antagonist Production by Type (2018-2029)
5.3.2 World H1 Receptor Antagonist Production Value by Type (2018-2029)
5.3.3 World H1 Receptor Antagonist Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World H1 Receptor Antagonist Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Retail Pharmacy
6.2.3 Other
6.3 Market Segment by Application
6.3.1 World H1 Receptor Antagonist Production by Application (2018-2029)
6.3.2 World H1 Receptor Antagonist Production Value by Application (2018-2029)
6.3.3 World H1 Receptor Antagonist Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Teva
7.1.1 Teva Details
7.1.2 Teva Major Business
7.1.3 Teva H1 Receptor Antagonist Product and Services
7.1.4 Teva H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Teva Recent Developments/Updates
7.1.6 Teva Competitive Strengths & Weaknesses
7.2 Bayer
7.2.1 Bayer Details
7.2.2 Bayer Major Business
7.2.3 Bayer H1 Receptor Antagonist Product and Services
7.2.4 Bayer H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Bayer Recent Developments/Updates
7.2.6 Bayer Competitive Strengths & Weaknesses
7.3 Pfizer
7.3.1 Pfizer Details
7.3.2 Pfizer Major Business
7.3.3 Pfizer H1 Receptor Antagonist Product and Services
7.3.4 Pfizer H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Pfizer Recent Developments/Updates
7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 LETI
7.4.1 LETI Details
7.4.2 LETI Major Business
7.4.3 LETI H1 Receptor Antagonist Product and Services
7.4.4 LETI H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 LETI Recent Developments/Updates
7.4.6 LETI Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis H1 Receptor Antagonist Product and Services
7.5.4 Novartis H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Hypera Pharma
7.6.1 Hypera Pharma Details
7.6.2 Hypera Pharma Major Business
7.6.3 Hypera Pharma H1 Receptor Antagonist Product and Services
7.6.4 Hypera Pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Hypera Pharma Recent Developments/Updates
7.6.6 Hypera Pharma Competitive Strengths & Weaknesses
7.7 Woodward
7.7.1 Woodward Details
7.7.2 Woodward Major Business
7.7.3 Woodward H1 Receptor Antagonist Product and Services
7.7.4 Woodward H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Woodward Recent Developments/Updates
7.7.6 Woodward Competitive Strengths & Weaknesses
7.8 Merck
7.8.1 Merck Details
7.8.2 Merck Major Business
7.8.3 Merck H1 Receptor Antagonist Product and Services
7.8.4 Merck H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Merck Recent Developments/Updates
7.8.6 Merck Competitive Strengths & Weaknesses
7.9 Johnson and Johnson
7.9.1 Johnson and Johnson Details
7.9.2 Johnson and Johnson Major Business
7.9.3 Johnson and Johnson H1 Receptor Antagonist Product and Services
7.9.4 Johnson and Johnson H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Johnson and Johnson Recent Developments/Updates
7.9.6 Johnson and Johnson Competitive Strengths & Weaknesses
7.10 Ethical pharma
7.10.1 Ethical pharma Details
7.10.2 Ethical pharma Major Business
7.10.3 Ethical pharma H1 Receptor Antagonist Product and Services
7.10.4 Ethical pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Ethical pharma Recent Developments/Updates
7.10.6 Ethical pharma Competitive Strengths & Weaknesses
7.11 Gems pharma
7.11.1 Gems pharma Details
7.11.2 Gems pharma Major Business
7.11.3 Gems pharma H1 Receptor Antagonist Product and Services
7.11.4 Gems pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Gems pharma Recent Developments/Updates
7.11.6 Gems pharma Competitive Strengths & Weaknesses
7.12 KPL Pharma
7.12.1 KPL Pharma Details
7.12.2 KPL Pharma Major Business
7.12.3 KPL Pharma H1 Receptor Antagonist Product and Services
7.12.4 KPL Pharma H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 KPL Pharma Recent Developments/Updates
7.12.6 KPL Pharma Competitive Strengths & Weaknesses
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Details
7.13.2 GlaxoSmithKline Major Business
7.13.3 GlaxoSmithKline H1 Receptor Antagonist Product and Services
7.13.4 GlaxoSmithKline H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 GlaxoSmithKline Recent Developments/Updates
7.13.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.14 Ying Yuan
7.14.1 Ying Yuan Details
7.14.2 Ying Yuan Major Business
7.14.3 Ying Yuan H1 Receptor Antagonist Product and Services
7.14.4 Ying Yuan H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Ying Yuan Recent Developments/Updates
7.14.6 Ying Yuan Competitive Strengths & Weaknesses
7.15 Schering-Plough
7.15.1 Schering-Plough Details
7.15.2 Schering-Plough Major Business
7.15.3 Schering-Plough H1 Receptor Antagonist Product and Services
7.15.4 Schering-Plough H1 Receptor Antagonist Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Schering-Plough Recent Developments/Updates
7.15.6 Schering-Plough Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 H1 Receptor Antagonist Industry Chain
8.2 H1 Receptor Antagonist Upstream Analysis
8.2.1 H1 Receptor Antagonist Core Raw Materials
8.2.2 Main Manufacturers of H1 Receptor Antagonist Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 H1 Receptor Antagonist Production Mode
8.6 H1 Receptor Antagonist Procurement Model
8.7 H1 Receptor Antagonist Industry Sales Model and Sales Channels
8.7.1 H1 Receptor Antagonist Sales Model
8.7.2 H1 Receptor Antagonist Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World H1 Receptor Antagonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World H1 Receptor Antagonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World H1 Receptor Antagonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World H1 Receptor Antagonist Production Value Market Share by Region (2018-2023)
Table 5. World H1 Receptor Antagonist Production Value Market Share by Region (2024-2029)
Table 6. World H1 Receptor Antagonist Production by Region (2018-2023) & (K Units)
Table 7. World H1 Receptor Antagonist Production by Region (2024-2029) & (K Units)
Table 8. World H1 Receptor Antagonist Production Market Share by Region (2018-2023)
Table 9. World H1 Receptor Antagonist Production Market Share by Region (2024-2029)
Table 10. World H1 Receptor Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World H1 Receptor Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 12. H1 Receptor Antagonist Major Market Trends
Table 13. World H1 Receptor Antagonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World H1 Receptor Antagonist Consumption by Region (2018-2023) & (K Units)
Table 15. World H1 Receptor Antagonist Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World H1 Receptor Antagonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key H1 Receptor Antagonist Producers in 2022
Table 18. World H1 Receptor Antagonist Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key H1 Receptor Antagonist Producers in 2022
Table 20. World H1 Receptor Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global H1 Receptor Antagonist Company Evaluation Quadrant
Table 22. World H1 Receptor Antagonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and H1 Receptor Antagonist Production Site of Key Manufacturer
Table 24. H1 Receptor Antagonist Market: Company Product Type Footprint
Table 25. H1 Receptor Antagonist Market: Company Product Application Footprint
Table 26. H1 Receptor Antagonist Competitive Factors
Table 27. H1 Receptor Antagonist New Entrant and Capacity Expansion Plans
Table 28. H1 Receptor Antagonist Mergers & Acquisitions Activity
Table 29. United States VS China H1 Receptor Antagonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China H1 Receptor Antagonist Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China H1 Receptor Antagonist Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers H1 Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers H1 Receptor Antagonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers H1 Receptor Antagonist Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers H1 Receptor Antagonist Production Market Share (2018-2023)
Table 37. China Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers H1 Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers H1 Receptor Antagonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers H1 Receptor Antagonist Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers H1 Receptor Antagonist Production Market Share (2018-2023)
Table 42. Rest of World Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers H1 Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers H1 Receptor Antagonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers H1 Receptor Antagonist Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers H1 Receptor Antagonist Production Market Share (2018-2023)
Table 47. World H1 Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World H1 Receptor Antagonist Production by Type (2018-2023) & (K Units)
Table 49. World H1 Receptor Antagonist Production by Type (2024-2029) & (K Units)
Table 50. World H1 Receptor Antagonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World H1 Receptor Antagonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World H1 Receptor Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World H1 Receptor Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World H1 Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World H1 Receptor Antagonist Production by Application (2018-2023) & (K Units)
Table 56. World H1 Receptor Antagonist Production by Application (2024-2029) & (K Units)
Table 57. World H1 Receptor Antagonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World H1 Receptor Antagonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World H1 Receptor Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World H1 Receptor Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Basic Information, Manufacturing Base and Competitors
Table 62. Teva Major Business
Table 63. Teva H1 Receptor Antagonist Product and Services
Table 64. Teva H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Recent Developments/Updates
Table 66. Teva Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer H1 Receptor Antagonist Product and Services
Table 70. Bayer H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer H1 Receptor Antagonist Product and Services
Table 76. Pfizer H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. LETI Basic Information, Manufacturing Base and Competitors
Table 80. LETI Major Business
Table 81. LETI H1 Receptor Antagonist Product and Services
Table 82. LETI H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. LETI Recent Developments/Updates
Table 84. LETI Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis H1 Receptor Antagonist Product and Services
Table 88. Novartis H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Hypera Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Hypera Pharma Major Business
Table 93. Hypera Pharma H1 Receptor Antagonist Product and Services
Table 94. Hypera Pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hypera Pharma Recent Developments/Updates
Table 96. Hypera Pharma Competitive Strengths & Weaknesses
Table 97. Woodward Basic Information, Manufacturing Base and Competitors
Table 98. Woodward Major Business
Table 99. Woodward H1 Receptor Antagonist Product and Services
Table 100. Woodward H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Woodward Recent Developments/Updates
Table 102. Woodward Competitive Strengths & Weaknesses
Table 103. Merck Basic Information, Manufacturing Base and Competitors
Table 104. Merck Major Business
Table 105. Merck H1 Receptor Antagonist Product and Services
Table 106. Merck H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Merck Recent Developments/Updates
Table 108. Merck Competitive Strengths & Weaknesses
Table 109. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 110. Johnson and Johnson Major Business
Table 111. Johnson and Johnson H1 Receptor Antagonist Product and Services
Table 112. Johnson and Johnson H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Johnson and Johnson Recent Developments/Updates
Table 114. Johnson and Johnson Competitive Strengths & Weaknesses
Table 115. Ethical pharma Basic Information, Manufacturing Base and Competitors
Table 116. Ethical pharma Major Business
Table 117. Ethical pharma H1 Receptor Antagonist Product and Services
Table 118. Ethical pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Ethical pharma Recent Developments/Updates
Table 120. Ethical pharma Competitive Strengths & Weaknesses
Table 121. Gems pharma Basic Information, Manufacturing Base and Competitors
Table 122. Gems pharma Major Business
Table 123. Gems pharma H1 Receptor Antagonist Product and Services
Table 124. Gems pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Gems pharma Recent Developments/Updates
Table 126. Gems pharma Competitive Strengths & Weaknesses
Table 127. KPL Pharma Basic Information, Manufacturing Base and Competitors
Table 128. KPL Pharma Major Business
Table 129. KPL Pharma H1 Receptor Antagonist Product and Services
Table 130. KPL Pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. KPL Pharma Recent Developments/Updates
Table 132. KPL Pharma Competitive Strengths & Weaknesses
Table 133. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 134. GlaxoSmithKline Major Business
Table 135. GlaxoSmithKline H1 Receptor Antagonist Product and Services
Table 136. GlaxoSmithKline H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. GlaxoSmithKline Recent Developments/Updates
Table 138. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 139. Ying Yuan Basic Information, Manufacturing Base and Competitors
Table 140. Ying Yuan Major Business
Table 141. Ying Yuan H1 Receptor Antagonist Product and Services
Table 142. Ying Yuan H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ying Yuan Recent Developments/Updates
Table 144. Schering-Plough Basic Information, Manufacturing Base and Competitors
Table 145. Schering-Plough Major Business
Table 146. Schering-Plough H1 Receptor Antagonist Product and Services
Table 147. Schering-Plough H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of H1 Receptor Antagonist Upstream (Raw Materials)
Table 149. H1 Receptor Antagonist Typical Customers
Table 150. H1 Receptor Antagonist Typical Distributors
List of Figure
Figure 1. H1 Receptor Antagonist Picture
Figure 2. World H1 Receptor Antagonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World H1 Receptor Antagonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 5. World H1 Receptor Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 6. World H1 Receptor Antagonist Production Value Market Share by Region (2018-2029)
Figure 7. World H1 Receptor Antagonist Production Market Share by Region (2018-2029)
Figure 8. North America H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 9. Europe H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 10. China H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 11. Japan H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 12. H1 Receptor Antagonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 15. World H1 Receptor Antagonist Consumption Market Share by Region (2018-2029)
Figure 16. United States H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 17. China H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 18. Europe H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 19. Japan H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 20. South Korea H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 21. ASEAN H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 22. India H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of H1 Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for H1 Receptor Antagonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for H1 Receptor Antagonist Markets in 2022
Figure 26. United States VS China: H1 Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: H1 Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: H1 Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers H1 Receptor Antagonist Production Market Share 2022
Figure 30. China Based Manufacturers H1 Receptor Antagonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers H1 Receptor Antagonist Production Market Share 2022
Figure 32. World H1 Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World H1 Receptor Antagonist Production Value Market Share by Type in 2022
Figure 34. First Generation H1RAS
Figure 35. Second-generation H1RAS
Figure 36. Third-generation H1RAS
Figure 37. World H1 Receptor Antagonist Production Market Share by Type (2018-2029)
Figure 38. World H1 Receptor Antagonist Production Value Market Share by Type (2018-2029)
Figure 39. World H1 Receptor Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World H1 Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World H1 Receptor Antagonist Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Retail Pharmacy
Figure 44. Other
Figure 45. World H1 Receptor Antagonist Production Market Share by Application (2018-2029)
Figure 46. World H1 Receptor Antagonist Production Value Market Share by Application (2018-2029)
Figure 47. World H1 Receptor Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. H1 Receptor Antagonist Industry Chain
Figure 49. H1 Receptor Antagonist Procurement Model
Figure 50. H1 Receptor Antagonist Sales Model
Figure 51. H1 Receptor Antagonist Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Table 1. World H1 Receptor Antagonist Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World H1 Receptor Antagonist Production Value by Region (2018-2023) & (USD Million)
Table 3. World H1 Receptor Antagonist Production Value by Region (2024-2029) & (USD Million)
Table 4. World H1 Receptor Antagonist Production Value Market Share by Region (2018-2023)
Table 5. World H1 Receptor Antagonist Production Value Market Share by Region (2024-2029)
Table 6. World H1 Receptor Antagonist Production by Region (2018-2023) & (K Units)
Table 7. World H1 Receptor Antagonist Production by Region (2024-2029) & (K Units)
Table 8. World H1 Receptor Antagonist Production Market Share by Region (2018-2023)
Table 9. World H1 Receptor Antagonist Production Market Share by Region (2024-2029)
Table 10. World H1 Receptor Antagonist Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World H1 Receptor Antagonist Average Price by Region (2024-2029) & (US$/Unit)
Table 12. H1 Receptor Antagonist Major Market Trends
Table 13. World H1 Receptor Antagonist Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World H1 Receptor Antagonist Consumption by Region (2018-2023) & (K Units)
Table 15. World H1 Receptor Antagonist Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World H1 Receptor Antagonist Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key H1 Receptor Antagonist Producers in 2022
Table 18. World H1 Receptor Antagonist Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key H1 Receptor Antagonist Producers in 2022
Table 20. World H1 Receptor Antagonist Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global H1 Receptor Antagonist Company Evaluation Quadrant
Table 22. World H1 Receptor Antagonist Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and H1 Receptor Antagonist Production Site of Key Manufacturer
Table 24. H1 Receptor Antagonist Market: Company Product Type Footprint
Table 25. H1 Receptor Antagonist Market: Company Product Application Footprint
Table 26. H1 Receptor Antagonist Competitive Factors
Table 27. H1 Receptor Antagonist New Entrant and Capacity Expansion Plans
Table 28. H1 Receptor Antagonist Mergers & Acquisitions Activity
Table 29. United States VS China H1 Receptor Antagonist Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China H1 Receptor Antagonist Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China H1 Receptor Antagonist Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers H1 Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers H1 Receptor Antagonist Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers H1 Receptor Antagonist Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers H1 Receptor Antagonist Production Market Share (2018-2023)
Table 37. China Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers H1 Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers H1 Receptor Antagonist Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers H1 Receptor Antagonist Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers H1 Receptor Antagonist Production Market Share (2018-2023)
Table 42. Rest of World Based H1 Receptor Antagonist Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers H1 Receptor Antagonist Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers H1 Receptor Antagonist Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers H1 Receptor Antagonist Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers H1 Receptor Antagonist Production Market Share (2018-2023)
Table 47. World H1 Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World H1 Receptor Antagonist Production by Type (2018-2023) & (K Units)
Table 49. World H1 Receptor Antagonist Production by Type (2024-2029) & (K Units)
Table 50. World H1 Receptor Antagonist Production Value by Type (2018-2023) & (USD Million)
Table 51. World H1 Receptor Antagonist Production Value by Type (2024-2029) & (USD Million)
Table 52. World H1 Receptor Antagonist Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World H1 Receptor Antagonist Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World H1 Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World H1 Receptor Antagonist Production by Application (2018-2023) & (K Units)
Table 56. World H1 Receptor Antagonist Production by Application (2024-2029) & (K Units)
Table 57. World H1 Receptor Antagonist Production Value by Application (2018-2023) & (USD Million)
Table 58. World H1 Receptor Antagonist Production Value by Application (2024-2029) & (USD Million)
Table 59. World H1 Receptor Antagonist Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World H1 Receptor Antagonist Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Teva Basic Information, Manufacturing Base and Competitors
Table 62. Teva Major Business
Table 63. Teva H1 Receptor Antagonist Product and Services
Table 64. Teva H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Teva Recent Developments/Updates
Table 66. Teva Competitive Strengths & Weaknesses
Table 67. Bayer Basic Information, Manufacturing Base and Competitors
Table 68. Bayer Major Business
Table 69. Bayer H1 Receptor Antagonist Product and Services
Table 70. Bayer H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Bayer Recent Developments/Updates
Table 72. Bayer Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer H1 Receptor Antagonist Product and Services
Table 76. Pfizer H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. LETI Basic Information, Manufacturing Base and Competitors
Table 80. LETI Major Business
Table 81. LETI H1 Receptor Antagonist Product and Services
Table 82. LETI H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. LETI Recent Developments/Updates
Table 84. LETI Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis H1 Receptor Antagonist Product and Services
Table 88. Novartis H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Hypera Pharma Basic Information, Manufacturing Base and Competitors
Table 92. Hypera Pharma Major Business
Table 93. Hypera Pharma H1 Receptor Antagonist Product and Services
Table 94. Hypera Pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Hypera Pharma Recent Developments/Updates
Table 96. Hypera Pharma Competitive Strengths & Weaknesses
Table 97. Woodward Basic Information, Manufacturing Base and Competitors
Table 98. Woodward Major Business
Table 99. Woodward H1 Receptor Antagonist Product and Services
Table 100. Woodward H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Woodward Recent Developments/Updates
Table 102. Woodward Competitive Strengths & Weaknesses
Table 103. Merck Basic Information, Manufacturing Base and Competitors
Table 104. Merck Major Business
Table 105. Merck H1 Receptor Antagonist Product and Services
Table 106. Merck H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Merck Recent Developments/Updates
Table 108. Merck Competitive Strengths & Weaknesses
Table 109. Johnson and Johnson Basic Information, Manufacturing Base and Competitors
Table 110. Johnson and Johnson Major Business
Table 111. Johnson and Johnson H1 Receptor Antagonist Product and Services
Table 112. Johnson and Johnson H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Johnson and Johnson Recent Developments/Updates
Table 114. Johnson and Johnson Competitive Strengths & Weaknesses
Table 115. Ethical pharma Basic Information, Manufacturing Base and Competitors
Table 116. Ethical pharma Major Business
Table 117. Ethical pharma H1 Receptor Antagonist Product and Services
Table 118. Ethical pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Ethical pharma Recent Developments/Updates
Table 120. Ethical pharma Competitive Strengths & Weaknesses
Table 121. Gems pharma Basic Information, Manufacturing Base and Competitors
Table 122. Gems pharma Major Business
Table 123. Gems pharma H1 Receptor Antagonist Product and Services
Table 124. Gems pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Gems pharma Recent Developments/Updates
Table 126. Gems pharma Competitive Strengths & Weaknesses
Table 127. KPL Pharma Basic Information, Manufacturing Base and Competitors
Table 128. KPL Pharma Major Business
Table 129. KPL Pharma H1 Receptor Antagonist Product and Services
Table 130. KPL Pharma H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. KPL Pharma Recent Developments/Updates
Table 132. KPL Pharma Competitive Strengths & Weaknesses
Table 133. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 134. GlaxoSmithKline Major Business
Table 135. GlaxoSmithKline H1 Receptor Antagonist Product and Services
Table 136. GlaxoSmithKline H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. GlaxoSmithKline Recent Developments/Updates
Table 138. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 139. Ying Yuan Basic Information, Manufacturing Base and Competitors
Table 140. Ying Yuan Major Business
Table 141. Ying Yuan H1 Receptor Antagonist Product and Services
Table 142. Ying Yuan H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Ying Yuan Recent Developments/Updates
Table 144. Schering-Plough Basic Information, Manufacturing Base and Competitors
Table 145. Schering-Plough Major Business
Table 146. Schering-Plough H1 Receptor Antagonist Product and Services
Table 147. Schering-Plough H1 Receptor Antagonist Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of H1 Receptor Antagonist Upstream (Raw Materials)
Table 149. H1 Receptor Antagonist Typical Customers
Table 150. H1 Receptor Antagonist Typical Distributors
List of Figure
Figure 1. H1 Receptor Antagonist Picture
Figure 2. World H1 Receptor Antagonist Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World H1 Receptor Antagonist Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 5. World H1 Receptor Antagonist Average Price (2018-2029) & (US$/Unit)
Figure 6. World H1 Receptor Antagonist Production Value Market Share by Region (2018-2029)
Figure 7. World H1 Receptor Antagonist Production Market Share by Region (2018-2029)
Figure 8. North America H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 9. Europe H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 10. China H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 11. Japan H1 Receptor Antagonist Production (2018-2029) & (K Units)
Figure 12. H1 Receptor Antagonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 15. World H1 Receptor Antagonist Consumption Market Share by Region (2018-2029)
Figure 16. United States H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 17. China H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 18. Europe H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 19. Japan H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 20. South Korea H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 21. ASEAN H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 22. India H1 Receptor Antagonist Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of H1 Receptor Antagonist by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for H1 Receptor Antagonist Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for H1 Receptor Antagonist Markets in 2022
Figure 26. United States VS China: H1 Receptor Antagonist Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: H1 Receptor Antagonist Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: H1 Receptor Antagonist Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers H1 Receptor Antagonist Production Market Share 2022
Figure 30. China Based Manufacturers H1 Receptor Antagonist Production Market Share 2022
Figure 31. Rest of World Based Manufacturers H1 Receptor Antagonist Production Market Share 2022
Figure 32. World H1 Receptor Antagonist Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World H1 Receptor Antagonist Production Value Market Share by Type in 2022
Figure 34. First Generation H1RAS
Figure 35. Second-generation H1RAS
Figure 36. Third-generation H1RAS
Figure 37. World H1 Receptor Antagonist Production Market Share by Type (2018-2029)
Figure 38. World H1 Receptor Antagonist Production Value Market Share by Type (2018-2029)
Figure 39. World H1 Receptor Antagonist Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World H1 Receptor Antagonist Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World H1 Receptor Antagonist Production Value Market Share by Application in 2022
Figure 42. Hospital
Figure 43. Retail Pharmacy
Figure 44. Other
Figure 45. World H1 Receptor Antagonist Production Market Share by Application (2018-2029)
Figure 46. World H1 Receptor Antagonist Production Value Market Share by Application (2018-2029)
Figure 47. World H1 Receptor Antagonist Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. H1 Receptor Antagonist Industry Chain
Figure 49. H1 Receptor Antagonist Procurement Model
Figure 50. H1 Receptor Antagonist Sales Model
Figure 51. H1 Receptor Antagonist Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
